Physiogenex will be presenting a poster at the Keystone Symposia – Lessons from the pandemic to be held in Snowbird, UT, USA on April 10th-13th.

The poster entitled “Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters” will be presented by Dr. François Briand, Director of Research and Business Development, on Monday April the 11th during the evening poster#1 session (poster #1008).

Feel free to contact us if you wish to set-up an appointment with our poster presenter Dr. François Briand, and/or discuss your drug development projects with us.

About us

Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications.

We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis), cardiovascular and renal complications.